Mutations des prot??ines de la coagulation et thromboses, m??decine/sciences, vol.22, issue.11, pp.985-994, 2006. ,
DOI : 10.1051/medsci/20062211985
Groupe d'Etude de la Thrombose de Bretagne Occidentale. Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study, Thromb Haemost, vol.83, issue.5, pp.657-60, 2000. ,
URL : https://hal.archives-ouvertes.fr/hal-00726218
La maladie veineuse thromboembolique??: patients hospitalis??s et mortalit?? en France en 2010, Journal des Maladies Vasculaires, vol.38, issue.5, pp.33-34417, 2013. ,
DOI : 10.1016/j.jmv.2013.07.040
Contraception hormonale et risque thromboembolique veineux??: quand demander une ??tude de l???h??mostase??? Et laquelle???, Gyn??cologie Obst??trique & Fertilit??, vol.36, issue.4, pp.448-454, 2008. ,
DOI : 10.1016/j.gyobfe.2008.02.006
Natural history of pulmonary embolism Prog, Cardiovasc. Dis, vol.17, pp.159-170, 1975. ,
Late Prognosis of Acute Pulmonary Embolism, New England Journal of Medicine, vol.289, issue.2, pp.55-58, 1973. ,
DOI : 10.1056/NEJM197307122890201
Incidence and mortality of venous thrombosis: a population-based study, Journal of Thrombosis and Haemostasis, vol.34, issue.4, pp.692-701, 2007. ,
DOI : 10.1056/NEJM200012213432504
Cardiovascular Risk Factors and Venous Thromboembolism: A Meta-Analysis, Circulation, vol.117, issue.1, pp.93-102, 2008. ,
DOI : 10.1161/CIRCULATIONAHA.107.709204
Genetic susceptibility, smoking, obesity and risk of venous thromboembolism, British Journal of Haematology, vol.12, issue.2, pp.273-279, 2010. ,
DOI : 10.1111/j.1365-2141.2010.08086.x
Thrombose veineuse des membres inférieurs et de la veine cave inférieure, Encycl Med Chirg, vol.2004, pp.80-96 ,
Smoking and risk of venous thromboembolism : a systematc review. Southeast Asian J Trop Med Public HEalth, pp.736-781, 2014. ,
Obesity as a risk factor in venous thromboembolism, The American Journal of Medicine, vol.118, issue.9, pp.978-980, 2005. ,
DOI : 10.1016/j.amjmed.2005.03.012
Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations, British Journal of Haematology, vol.19, issue.2, pp.289-296, 2007. ,
DOI : 10.1056/NEJM200012143432403
Genetic Susceptibility to Thrombosis and Its Relationship to Physiological Risk Factors: The GAIT Study, The American Journal of Human Genetics, vol.67, issue.6, pp.1452-1459, 2000. ,
DOI : 10.1086/316903
Major Genetic Susceptibility for Venous Thromboembolism in Men: A Study of Danish Twins, Epidemiology, vol.14, issue.3, pp.328-332, 2003. ,
DOI : 10.1097/01.EDE.0000060457.51194.BC
Age- and Gender-Specific Familial Risks for Venous Thromboembolism: A Nationwide Epidemiological Study Based on Hospitalizations in Sweden, Circulation, vol.124, issue.9, pp.1012-1032, 2011. ,
DOI : 10.1161/CIRCULATIONAHA.110.965020
Factors That Predict Risk of Thrombosis in Relatives of Patients With Unprovoked Venous Thromboembolism, Chest, vol.136, issue.6, pp.1537-1582, 2009. ,
DOI : 10.1378/chest.09-0757
URL : https://hal.archives-ouvertes.fr/hal-00683296
Thromboembolism in Inflammatory Bowel Disease: An Insidious Association Requiring a High Degree of Vigilance, Seminars in Thrombosis and Hemostasis, vol.37, issue.03, pp.220-225, 2011. ,
DOI : 10.1055/s-0031-1273086
Risk of Venous Thromboembolism in Patients With Rheumatoid Arthritis and Association With Disease Duration and Hospitalization, JAMA, vol.308, issue.13, pp.1350-1356, 2012. ,
DOI : 10.1001/2012.jama.11741
Socioeconomic factors and concomitant diseases are related to the risk for venous thromboembolism during long time follow-up, Journal of Thrombosis and Thrombolysis, vol.241, issue.5, pp.58-64, 2013. ,
DOI : 10.1007/s11239-012-0858-8
Epidemiology, diagnosis, treatment and management of superficial-vein thrombosis of the legs, Best Practice & Research Clinical Haematology, vol.25, issue.3, pp.275-284, 2012. ,
DOI : 10.1016/j.beha.2012.07.005
Increased risk of venous thrombosis in persons with clinically diagnosed superficial vein thrombosis: results from the MEGA study, Blood, vol.118, issue.15, pp.118-133, 2011. ,
DOI : 10.1182/blood-2011-05-356071
The risk of venous thrombosis in individuals with a history of superficial vein thrombosis and acquired venous thrombotic risk factors, Blood, vol.122, issue.26, pp.122-148, 2013. ,
DOI : 10.1182/blood-2013-07-518159
Superficial Vein Thrombosis in Patients with Varicose Veins: Role of Thrombophilia Factors, Age and Body Mass, European Journal of Vascular and Endovascular Surgery, vol.43, issue.3, pp.355-358, 2012. ,
DOI : 10.1016/j.ejvs.2011.12.019
Recurrent Venous Thromboembolism After Deep Vein Thrombosis, Archives of Internal Medicine, vol.160, issue.6, pp.769-74, 2000. ,
DOI : 10.1001/archinte.160.6.769
The risk of deep vein thrombosis : a computerized epidemiologic approach, Surgery, vol.101, pp.205-217, 1987. ,
Frequency and timing of clinical venous thromboembolism after major joint surgery, Journal of Bone and Joint Surgery - British Volume, vol.88, issue.3, pp.386-391, 2006. ,
DOI : 10.1302/0301-620X.88B3.17207
Incidence of symptomatic venous thromboembolismafter different electiveorurgent surgical procedures, ThrombHae-most, vol.90, pp.367-368, 2003. ,
Symptomatic venous thromboembolism and mortality in orthopaedic surgery ??? an observational study of 45 968 consecutive procedures, BMC Musculoskeletal Disorders, vol.108, issue.Suppl 6, p.177, 2013. ,
DOI : 10.1378/chest.108.4.978
Prévention de la maladie thromboembolique veineuse postopératoire. Actualisation Texte court. Annales Françaises d'Anesthésie et de, ca05_24.htm 33-Pernod G, et al. Recommandations pour la recherche de facteurs biologiques de risque dans le cadre de la maladie thromboembolique veineuse: applications cliniques, pp.947-951, 2009. ,
Venous thromboembosis : the roles of genes, environnment, and behavior, Hematology Am Soc Hematol Educ Program, pp.1-12, 2005. ,
Meta-analysis: Travel and Risk for Venous Thromboembolism, Annals of Internal Medicine, vol.151, issue.3, pp.180-190, 2009. ,
DOI : 10.7326/0003-4819-151-3-200908040-00129
Maladie thromboembolique des voyages a??riens, EMC - Ang??iologie, vol.7, issue.1, pp.1-5, 2012. ,
DOI : 10.1016/S1290-0176(12)49702-2
Venous thrombosis: a multicausal disease, The Lancet, vol.353, issue.9159, pp.1167-73, 1999. ,
DOI : 10.1016/S0140-6736(98)10266-0
Inherited antithrombin deficiency causing thrombophilia, Thromb Diath Haemorr, vol.13, pp.516-546, 1965. ,
Deficiency of protein C in congenital thrombotic disease., Journal of Clinical Investigation, vol.68, issue.5, pp.1370-1373, 1981. ,
DOI : 10.1172/JCI110385
Familial protein S deficiency is associated with recurrent thrombosis., Journal of Clinical Investigation, vol.74, issue.6, pp.2082-2090, 1984. ,
DOI : 10.1172/JCI111632
Familial thrombophilia and lifetime risk of venous thrombosis, Journal of Thrombosis and Haemostasis, vol.89, issue.9, pp.1526-1558, 2004. ,
DOI : 10.1111/j.1538-7836.2004.00852.x
Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT), Journal of Thrombosis and Haemostasis, vol.135, issue.3, pp.459-64, 2005. ,
DOI : 10.1016/S0140-6736(96)01109-9
Ethnic Distribution of Factor V Leiden in 4047 Men and Women, JAMA, vol.277, issue.16, p.1305, 1997. ,
DOI : 10.1001/jama.1997.03540400055031
Venous thromboembolism in women using hormonal contraceptives. Findings from the RIETE Registry, Thrombosis and Haemostasis, vol.101, pp.478-482, 2009. ,
DOI : 10.1160/TH08-10-0684
URL : https://hal.archives-ouvertes.fr/ujm-00439719
Increased risk of venous thrombosis in oralcontraceptive users who are carriersof factor V Leiden mutation, Lancet, vol.334, pp.1453-1457, 1994. ,
Oral contraceptives, hormone remplacement therapy, thrombophilias and risk of venous thromboembolism : a systematic review. The thrombosis : risk and economic assessment of thrombophilia screening (TREATS) Study, Thromb Haemost, vol.94, pp.17-25, 2005. ,
La contraception en pratique, de la situation clinique à la prescription, 2013. ,
Higher Risk of Venous Thrombosis During Early Use of Oral Contraceptives in Women With Inherited Clotting Defects, Archives of Internal Medicine, vol.160, issue.1, pp.49-52, 2000. ,
DOI : 10.1001/archinte.160.1.49
The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. American journal of obstetrics and gynecology, pp.369-73, 1989. ,
Definition of normal autoantibody levels in an apparently healthy population. Obstetrics and gynecology, pp.596-602, 1988. ,
Population-Based Incidence and Prevalence of Systemic Lupus Erythematosus: The Michigan Lupus Epidemiology and Surveillance Program, Arthritis & Rheumatology, vol.46, issue.2, pp.369-78, 2014. ,
DOI : 10.1002/art.38238
Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: A systematic review and meta-analysis, Autoimmunity Reviews, vol.13, issue.6, pp.595-608, 2014. ,
DOI : 10.1016/j.autrev.2013.11.004
Lupus nephritis and Raynaud???s phenomenon are significant risk factors for vascular thrombosis in SLE patients with positive antiphospholipid antibodies, Clinical Rheumatology, vol.91, issue.3, pp.345-51, 2008. ,
DOI : 10.1007/s10067-007-0721-z
Homocystéine et maladie veineuse thromboembolique : la fin d'une belle histoire ?, STV, vol.22, pp.144-153, 2010. ,
Venous thromboembolic disease and the prothrombin, methylene tetrahydrofolate reductase and factor V genes. Thrombosis and haemostasis, pp.506-516, 1999. ,
Third generation oral contraceptives and risk of venous thromboembolism, BMJ, vol.323, pp.1-9, 2001. ,
Hormonal contraceptives and venous thromboembolism: An epidemiological update, Best Practice & Research Clinical Endocrinology & Metabolism, vol.27, issue.1, pp.25-34, 2013. ,
DOI : 10.1016/j.beem.2012.11.002
Obesity: risk of venous thrombosis and the interaction with coagulation factorslevels and oral contraceptive use, Thrombosis and Haemostasis, vol.89, pp.493-498, 2003. ,
Can changes in sex hormone bindingglobulin predict the risk of venous thromboembolism with combiend oral contraceptive pill ?, Acta Obstet Gynecol Scand, vol.81, pp.482-490, 2002. ,
MECHANISMS IN ENDOCRINOLOGY: Epidemiology of hormonal contraceptives-related venous thromboembolism, European Journal of Endocrinology, vol.171, issue.6, pp.14-0527, 2014. ,
DOI : 10.1530/EJE-14-0527
Mechanisms of Estrogen-Induced Venous Thromboembolism, Thrombosis Research, vol.126, issue.1, pp.5-11, 2010. ,
DOI : 10.1016/j.thromres.2010.01.045
Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses : Danish cohort study, BMJ, vol.343, pp.2001-2010, 2011. ,
Venous thromboembolism amng new users of different oral contraceptives., The Lancet, vol.354, issue.9173, pp.127-128, 1999. ,
DOI : 10.1016/S0140-6736(99)01257-X
The venous thrombotic risk of oral contraceptives, effectsof oestrogen dose and progestogen type: results of the MEGA casecontrol study, British Medical Journal, vol.339, 2009. ,
Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis, BMJ, vol.347, issue.sep12 1, p.5298, 2013. ,
DOI : 10.1136/bmj.f5298
Third génération oral contraceptives and risk of venous thromboembolism, BMJ, vol.323, pp.1-9, 2001. ,
Venous and pulmonary thromboembolism and combined hormonal contraceptives. Systematic review and meta-analysis. The European Journal of Contraception and Reproductive Health Care, pp.7-29, 2012. ,
Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparations., BMJ, vol.280, issue.6224, pp.1157-1161, 1980. ,
DOI : 10.1136/bmj.280.6224.1157
Hormone therapies and venous thromboembolism: where are we now?, Journal of Thrombosis and Haemostasis, vol.84, issue.Suppl. 6, pp.257-266, 2011. ,
DOI : 10.1111/j.1538-7836.2010.04148.x
Impact of progestagens on activated protein C (APC) resistance among users of oral contraceptives, Journal of Thrombosis and Haemostasis, vol.103, issue.Suppl. 1, pp.1594-1600, 2004. ,
DOI : 10.1111/j.1538-7836.2004.00894.x
Sex hormone-binding globulin as a marker for the thrombotic risk of hormonal contraceptives, Journal of Thrombosis and Haemostasis, vol.877, issue.6, pp.992-997, 2012. ,
DOI : 10.1111/j.1538-7836.2012.04720.x
Hemostatic Effects of a Novel Estradiol-Based Oral Contraceptive, Drugs in R&D, vol.4, issue.Suppl.2, pp.159-170, 2011. ,
DOI : 10.2165/11591200-000000000-00000
Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17??-oestradiol compared with one containing levonorgestrel and ethinylestradiol on haemostasis, lipids and carbohydrate metabolism, The European Journal of Contraception & Reproductive Health Care, vol.81, issue.4, pp.444-457, 2011. ,
DOI : 10.1016/j.contraception.2005.09.015
Effects of Oral and Transvaginal Ethinyl Estradiol on Hemostatic Factors and Hepatic Proteins in a Randomized, Crossover Study, The Journal of Clinical Endocrinology & Metabolism, vol.92, issue.6, pp.2074-2079, 2007. ,
DOI : 10.1210/jc.2007-0026
Effects of the contraceptive patch, the vaginal ring and an oral contraceptiveon APC resistance and SHBG: a cross-over study, Thrombosis Research, vol.3, pp.429-435, 2009. ,
Comparison of a transdermal contraceptive patch vs. oral contraceptives on hemostasis variables, Contraception, vol.77, issue.2, pp.77-83, 2008. ,
DOI : 10.1016/j.contraception.2007.10.004
Progestin-only pills for contraception, Cochrane Database of Systemic Review, issue.1, p.7541, 2010. ,
DOI : 10.1002/14651858.cd007541.pub2
Limited knowledge on progestogen-only contraception and risk of venous thromboembolism, Acta Obstetricia et Gynecologica Scandinavica, vol.88, issue.3, pp.261-266, 2009. ,
DOI : 10.1080/00016340902730375
Progestin-only contraception and venous thromboembolism, Thrombosis Research, vol.129, issue.5, pp.257-262, 2012. ,
DOI : 10.1016/j.thromres.2012.02.042
Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis, BMJ, vol.345, issue.aug07 2, p.4944, 2012. ,
DOI : 10.1136/bmj.e4944
Risk factors for recurrence of venous thromboembolism associated with the use of oral contraceptives, Contraception, vol.84, issue.5, pp.23-30, 2011. ,
DOI : 10.1016/j.contraception.2011.06.008
Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10, BMJ, vol.344, issue.may10 3, p.2990, 2001. ,
DOI : 10.1136/bmj.e2990
Progestogen-only contraception in women at high risk of venous thromboembolism, Contraception, vol.70, issue.6, pp.437-441, 2004. ,
DOI : 10.1016/j.contraception.2004.07.009
Pregnane progestin contraception in systemic lupus erythematosus: a longitudinal study of 187 patients, Contraception, vol.83, issue.3, pp.229-237, 2011. ,
DOI : 10.1016/j.contraception.2010.08.012
Hormone Therapy and Venous Thromboembolism Among Postmenopausal Women: Impact of the Route of Estrogen Administration and Progestogens: The ESTHER Study, Circulation, vol.115, issue.7, pp.840-845, 2007. ,
DOI : 10.1161/CIRCULATIONAHA.106.642280
URL : https://hal.archives-ouvertes.fr/hal-00688234
Complications of IVF and ovulation induction, Human Reproduction, vol.20, issue.12, pp.3293-300, 2005. ,
DOI : 10.1093/humrep/dei253
The ???ART??? of thrombosis: a review of arterial and venous thrombosis in assisted reproductive technology, Current Opinion in Obstetrics and Gynecology, vol.21, issue.3, pp.207-225, 2009. ,
DOI : 10.1097/GCO.0b013e328329c2b8
Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles, Fertility and sterility, pp.15-02823600, 2012. ,
Incidence of pulmonary and venous thromboembolism in pregnancies after in vitro fertilisation: cross sectional study, BMJ, vol.346, issue.jan15 3, p.8632, 2013. ,
DOI : 10.1136/bmj.e8632
Trends in the Incidence of Venous Thromboembolism during Pregnancy or Postpartum: A 30-Year Population-Based Study, Annals of Internal Medicine, vol.143, issue.10, pp.697-706, 2005. ,
DOI : 10.7326/0003-4819-143-10-200511150-00006
Venous thromboembolism during pregnancy and the postpartum period: Incidence, risk factors, and mortality, American Journal of Obstetrics and Gynecology, vol.194, issue.5, pp.1311-1316, 2006. ,
DOI : 10.1016/j.ajog.2005.11.008
Hemostatic changes in pregnancy, Thromb res, pp.114-409, 2003. ,
Prospective evaluation of hemostatic system activation and thrombin potential, Thromb Haemost, vol.82, issue.4, pp.1232-1236, 1999. ,
Venous Thromboembolic Disease and Pregnancy, New England Journal of Medicine, vol.359, issue.19, pp.2025-2058, 2008. ,
DOI : 10.1056/NEJMra0707993
Cost-effectiveness of screening for the factor V Leiden mutation in pregnant women Venous Thromboembolic Disease and Pregnancy Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium--a register-based case-control study Deep vein thrombosis during pregnancy and the puerperium: a metaanalysis of the period of risk and leg of presentation 104- Hooman Kamel, Babak B. Navi, Nandita Sriram. Risk of a Thrombotic Event after the 6- Week Postpartum Period 105- Bonnar J. Can more be done in obstetric and gynecologic practice to reduce morbidity and mortality associated with venous thromboembolism? 106- Greer IA. Epidemiology, risk factors and prophylaxis of venous thrombo-embolism in obstetrics and gynaecology, Monreal M, Prandoni P. Venous thromboembolism as first manifestation of cancer, pp.1919-1939, 1997. ,
The location od deep vein thrombosis as a predictive factor for recurrence and cancer discovery after proximal deep-vein thrombosis Are venous thromboembolic events associated with subsequent breast and colorectal carcinoma diagnoses in the elderly ? A case control study of Medicare beneficiaries, Haematologica Cancer, vol.88106, pp.923-953, 2003. ,
Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer, The Lancet, vol.343, issue.8902, pp.886-889, 1994. ,
DOI : 10.1016/S0140-6736(94)90008-6
Evaluation of d-dimer in the diagnostis of suspected deep-vein thrombosis quoi de neuf ? Réanimation Deep-vein thrombosis N 116- http://www.armvop.fr/wp/?p=3401 117- http://www.has-sante.fr/portail/jcms/c_1369193/fr/contraception-fiches-memo 118- http D-dimer and factor VIII are independent risk factors for recurrence after anticoagulation withdrawal for the first idiopathic deep vein thrombosis D-dimer levels and risk of recuurent venous thromboembolism 122- Paul A. Kyrle. Venous thrombosis: who should be screened for thrombophilia in 2014 The family history and inherited thrombophilia The value of family history as a risk indicator for venous thrombosis, Thromb Haemost Thromb Haemost N Engl J Med Engl. J. Med. Thromb Res JAMA Pol Arch Med Wewn. Br J Haematol. Arch Intern Med, vol.758134929087169, issue.123, pp.251-253, 1994. ,
Association of the protein C promoter CG haplotype and the factor II G20210A mutation is a risk factor cerebral venous thrombosis Role of ABO blood group and of other risk factors on the presence of residual vein obtsruction after deep-vein thrombosis Effects of prothrombotic markers and non-O blood group in maternal venous thromboembolism during pregnancy and postpartum Venous thromboembolism in young female while on oral contraceptives : hight frequency of inherited thrombophilia and analysis of thrombotic events in 400 czech women PP. The risk of oral contracetives in the etiology on inflammatory bowel disease : a meta-analysis, Thèse pour l'obtention du diplôme d'état de doctorat en médecine Echecs répétés de fécondations in vitro, anomalies retrouvées au bilan diagnostic. 131- Cornish JA 132- Schmidt PM, Cornu P, Angelillo-Scherrer A. Bases physiopathologiques en hématologie générale, pp.495-500, 2005. ,